DFNS DFNS
Company Profile ↓Company Overview
DFNS (DFNS) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 5.8.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -72.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -47.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -47.57% |
| 1 Year: | -72.23% |
Stock Price Performance
| 1 Year: | +742.39% |
| 6 Months: | +1,940.44% |
| 3 Months: | +10,357.86% |
| 1 Month: | +32,004.90% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross5d ago
- RSI (14)58.82 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -47.6% CAGR over 5 years.
- Trading 46.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 5.38M | 5.63M | 5.21M | - | 5.24M | 259.76K | 175.21K | - | - | - | - | - | 3.65M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | -54.87K | 147.96K | -158.02K | - | 458.70K | 196.56K | 125.48K | - | - | - | - | - | 371.00K |
| Operating Income | -477 | - | -40 | -47.26K | -78.41K | -28.57K | -153.34K | -469.27K | -144.59K | -480.87K | -1.14M | -806.36K | -1.21M | -116.67K | -8.95M | -2.09M | -1.03M | -1.19M | -4.53M | -1.51M | -1.05M | -4.77M | -3.81M |
| Net Income | -477 | -124 | 67 | -41.43K | -20.37K | -21.34K | -124.61K | -460.28K | -35.54K | -578.75K | -1.13M | -805.65K | -1.21M | -126.06K | -8.93M | -2.43M | -1.62M | 4.46M | -160.79M | 102.96M | 3.02M | -16.37M | -27.15M |
| Diluted EPS | - | - | - | - | - | 0.00 | -0.02 | -0.08 | -0.01 | -0.13 | -0.11 | -0.08 | -0.12 | -0.07 | -0.85 | -0.17 | -0.90 | 2.18 | -51.96 | 18.15 | 0.54 | -2.02 | -1.14 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 274.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Sep 2022 | Dec 2022 | Sep 2023 | Sep 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 21.51M | - | 21.30M | 5.91M | - |
| Gross Profit | - | - | - | -661.40K | - | -343.14K | 998.52K | - |
| Operating Income | -20.66K | -148.01K | -670.92K | -11.14M | -1.20M | -17.46M | -7.11M | -32.60M |
| Net Income | -20.66K | -317.74K | -599.13K | -11.85M | -967.61K | -17.43M | -8.52M | 78.55M |
| Diluted EPS | - | - | -0.10 | -1.21 | -0.21 | -1.73 | -4.93 | 7.96 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Sep 2021 | Dec 2021 | Sep 2022 | Dec 2022 | Sep 2023 | Sep 2024 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 210.03K | 46.73M | - | 47.67M | 18.36M | 6.11M | 3.35M | 985.00K | 9.11M | 202.39M |
| Total Equity | 4.34K | 154.81K | 9.16M | -1.83M | 10.89M | -3.92M | -6.19M | -7.10M | -163.35M | -19.79M |
| Cash & Equivalents | 27.70K | 712.82K | - | - | 364.02K | - | 19.32K | 3.68K | 6.90M | 2.63M |
| Long Term Debt | - | - | - | - | - | - | - | 3.31M | - | - |
| Total Liabilities | 205.69K | 575.66K | - | 2.12M | 7.47M | 3.98M | 9.55M | 8.08M | 172.46M | 45.19M |
| Current Liabilities | 205.69K | 328.03K | - | 1.93M | 7.47M | 3.97M | 9.12M | 7.07M | 171.45M | 43.55M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Sep 2021 | Dec 2021 | Sep 2022 | Dec 2022 | Sep 2023 | Sep 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.24K | -137.08K | - | -430.91K | 1.62M | -1.13M | -1.23M | -3.82M | -6.20M |
| Investing Cash Flow | - | -46.00M | - | -1.38M | -35.00K | 47.39M | -1.11M | 133.00K | -179.83M |
| Financing Cash Flow | 47.94K | 46.82M | - | 1.38M | 0 | -40.43M | 418.32K | 3.00M | 181.99M |
| Capital Expenditure | - | - | - | - | - | - | -41.83K | - | -31.00K |
| Free Cash Flow | - | - | - | - | 1.62M | - | -1.27M | -3.82M | -6.23M |
| Net Change in Cash | - | - | - | - | 1.58M | - | -1.92M | -720.00K | -4.04M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Sep 2022 | Dec 2022 | Sep 2023 | Sep 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | -3.1% | - | -1.6% | 16.9% | - |
| Operating Margin % | - | - | - | -51.8% | - | -82.0% | -120.1% | - |
| Net Margin % | - | - | - | -55.1% | - | -81.8% | -144.1% | - |
| ROE % | -476.6% | -205.2% | 32.7% | -108.8% | 24.7% | 281.4% | 120.0% | -397.0% |
| ROCE % | -476.6% | -0.3% | -1.5% | -102.3% | -56.0% | 302.6% | 116.8% | -20.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DFNS
T3 Defense Subsidiary Tiltan Receives Purchase Order from Leading Israeli Defense Contractor for Next-Generation Infrared Electro-Optical Simulation Program
Initial HWIL Simulation Order Carries Potential to Scale to $2.0 MillionNEW YORK and NETANYA, Israel, Aug. 04, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (Nasdaq: DFNS) ("T3 Defense" or the "Company"), a defense technology holding company, to…
T3 Defense Inc. Subsidiaries Rimon and Tiltan Deliver Strong Year-to-Date Operating Performance
Both subsidiaries report record year-to-date revenue, new order intake, and backlog levelsNEW YORK and NETANYA, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), a defense technology h…
T3 Defense Subsidiary ITS Delivers Advanced Composite Materials Production Line to Leading Building Materials Manufacturer, Bringing Defense-Proven Fiberglass Technology to Industrial Scale
ITS Designs and Delivers a Custom Composite Materials Production Line, Extending Defense-Grade Fiber-Reinforced Composite Manufacturing to Industrial ScaleNEW YORK and NETANYA, Israel, July 20, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (Nasd…
CEO Chat with Menny Shalom, CEO of T3 Defense Inc.
NASDAQ: DFNS Tom Kerr, CFA: Hello, everyone. My name is Tom Kerr. I'm a senior equity analyst at Zacks Small Cap Research , and welcome to another episode of our CEO Chat program. Today we have the CEO of T3 Defense , Menny Shalom. T3 Defen…
T3 Defense Announces Reverse Stock Split
NEW YORK and NETANYA, Israel, July 16, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (NASDAQ: DFNS) (“T3 Defense” or the “Company”), a defense company that acquires and operates mission-critical defense businesses, today announced that its Board…
T3 Defense Subsidiary Rimon Delivers $1.1 Million Order with Major Israeli Defense Customer for Advanced Elevated Battlefield Lighting Systems
Highlights Growing Demand for Rapid-Deployment Illumination Solutions Across Border Security, Perimeter Defense, and Surveillance in Forward Operating EnvironmentsNEW YORK and NETANYA, Israel, July 13, 2026 (GLOBE NEWSWIRE) -- T3 Defense In…
DFNS — Frequently Asked Questions
What is the current share price of DFNS?
As of 2026-08-05 17:25 PDT, DFNS trades at $45.91 on NASDAQ/NYSE. Its 52-week range is $0.04 to $84.98.
What is the P/E ratio of DFNS?
DFNS trades at a trailing price-to-earnings (P/E) ratio of 5.77.
Is DFNS a good stock to buy?
This page provides a data-driven analysis of DFNS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.